Unfortunately, PTT-treatment also elevated the expression of the immune checkpoints such as PD-L1 level of tumor cells in vitro, which impairs anti-tumor immunity, resulting in the impediment of PTT therapy efficacy37. This evidence concerns the gene CD274 and neoplasm.